On April 16th, the Chronic Care Policy Alliance (CCPA) held a webinar that provided insights into the landscape of COVID-19 prevention and antiviral treatments. Moderated by CCPA’s Founder and CEO, Liz Helms, the webinar featured a lineup of experts, including Madeline Conway from Impact Research, Lynn Albizo from the Immune Deficiency Foundation, and Dr. Robert H. Hopkins, Jr. from the National Foundation for Infectious Diseases.
The panelists provided an overview of the current perceptions and accessibility of COVID-19 and antiviral therapies, among those over 50. Below are the key takeaways:
- Prevention and Intervention: Panelists highlighted the importance of preventing the spread of COVID-19 and ensuring the needs of the immunocompromised are met.
- Awareness and Accessibility: There is clearly a significant gap in public knowledge about COVID-19 antivirals among older adults who, while not overly concerned about the virus, strongly support better access to treatments. This underscores the ongoing need for targeted education and outreach efforts.
- Policy and Patient Care: Discussions also highlighted the importance of policy proposals that enhance access to these vital medications, ensuring they are affordable and readily available to those in need.
- Innovation and Future Direction: The panelists shed light on innovative approaches and ongoing research in the field of antiviral treatments, paving the way for future developments. This focus on innovation ensures that strategies evolve with the virus, helping us stay one step ahead in the fight against the evolving COVID-19.
The webinar is available on-demand for those who missed the live session or wish to revisit the discussions. You can access the recording here: https://bit.ly/3U1t9wC